Klaria adjusts annual report release date

Klaria Pharma Holding (publ) has announced that the 2025 annual report will be published on May 29th. As the annual general meeting has now been moved to June 26th, the annual report will be released on June 5th.

For more information, visit the  Klaria Pharma Holding website klaria.com or contact:
info@klaria.com
Tel: +46 (0) 8-446 42 99

This is Klaria Pharma Holding AB

Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative, rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and well proven pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Klaria is listed on Nasdaq First North Growth Markets under the short name KLAR. FNCA Sweden is Certified Advisor (info@fnca.se, +46(0) 8-528 00 399) for Klaria Pharma Holding AB. For more information, see www.klaria.com.